List of APIs/Active Pharmaceutical Ingredients Companies in Belgium - 3

Bioxodes is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of therapeutics for patients with thrombo-inflammatory diseases. We leverage our deep understanding of the thrombotic and inflammatory processes to design novel product candidates with an aim to address unmet medical needs.

Eurogentec, part of Kaneka Corporation, is an international biotechnology supplier, based in Belgium, who specializes in genomics and proteomics. The company is fully ISO 9001, ISO 13485 certified, cGMP accredited by the Belgian Ministry of Health and approved by the US FDA for the commercial manufacturing of a biologic for the US market. Eurogentec was founded in 1985. Through its three inter-related business units (BU), the company provides high quality products to scientists involved in the life science, biotechnology, diagnostic and pharmaceutical markets. The life science BU specializes in Genomics (e.g. Lab scale to Large scale Oligonucleotides, PCR/qPCR Kits & Reagents and Assay Dispensing Service) and Proteomics (e.g. catalog and custom peptides & antibodies including a 28-Day Speedy protocol, assay kits and Proprietary Dyes & Quenchers). The In Vitro Diagnostics BU provides technical and project support for contract manufacturing of GMP oligonucleotides and Taq DNA polymerases for use in Molecular Diagnostic applications. The Biomanufacturing BU is a GMP Biomanufacturer specialized in the technology transfer, process development, scale-up and manufacturing of proteins, plasmids and vaccines for pre-clinical, clinical and commercial uses, all according to FDA and EMA requirements.

EyeD Pharma is a clinical-stage pharmaceutical company based in Belgium, founded in 2012. The company is dedicated to improving the lives of patients with ophthalmic diseases, focusing on innovative therapeutic solutions for conditions like glaucoma and dry eye. EyeD Pharma specializes in developing drug products for ophthalmology, particularly through sustained-release polymeric micro-implants and inserts. Their product pipeline includes TimoD, a small molecule drug targeting β-adrenoceptors, aimed at enhancing patient compliance and minimizing treatment side effects. The company employs around 68 people and is structured as a holding company. EyeD Pharma's mission is to become a leader in the development of ophthalmic sustained-release micro-implants and complex therapeutics, addressing significant medical needs in the field.